Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Price Target

Price Target

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Hold on Wayfair, Lowers Price Target to $55

By Benzinga Newsdesk
July 15, 9:19 AM
Stifel analyst Scott Devitt maintains Wayfair (NYSE:W) with a Hold and lowers the price target from $60 to $55.

W

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on ACADIA Pharmaceuticals, Lowers Price Target to $22

By Benzinga Newsdesk
July 15, 9:13 AM
Morgan Stanley analyst Jeffrey Hung maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Equal-Weight and lowers the price target from $24 to $22.

ACAD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Underweight on Abiomed, Lowers Price Target to $235

By Benzinga Newsdesk
July 15, 9:09 AM
Morgan Stanley analyst David Lewis maintains Abiomed (NASDAQ:ABMD) with a Underweight and lowers the price target from $275 to $235.

ABMD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Hold on Canadian National Railway, Lowers Price Target to $113

By Benzinga Newsdesk
July 15, 9:05 AM
Stifel analyst Benjamin Nolan maintains Canadian National Railway (NYSE:CNI) with a Hold and lowers the price target from $124 to $113.

CNI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Hold on Canadian Pacific Railway, Raises Price Target to $79

By Benzinga Newsdesk
July 15, 9:03 AM
Stifel analyst Benjamin Nolan maintains Canadian Pacific Railway (NYSE:CP) with a Hold and raises the price target from $78 to $79.

CP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Deutsche Bank Maintains Hold on Conagra Brands, Lowers Price Target to $32

By Benzinga Newsdesk
July 15, 8:57 AM
Deutsche Bank analyst Steve Powers maintains Conagra Brands (NYSE:CAG) with a Hold and lowers the price target from $35 to $32.

CAG

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Buy on Etsy, Lowers Price Target to $125

By Benzinga Newsdesk
July 15, 8:53 AM
Stifel analyst Scott Devitt maintains Etsy (NASDAQ:ETSY) with a Buy and lowers the price target from $130 to $125.

ETSY

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Cowen & Co. Maintains Outperform on 10x Genomics, Lowers Price Target to $50

By Benzinga Newsdesk
July 15, 8:46 AM
Cowen & Co. analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Outperform and lowers the price target from $90 to $50.

TXG

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Stifel Maintains Buy on MercadoLibre, Lowers Price Target to $1000

By Benzinga Newsdesk
July 15, 8:45 AM
Stifel analyst Scott Devitt maintains MercadoLibre (NASDAQ:MELI) with a Buy and lowers the price target from $1200 to $1000.

MELI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Jefferies Maintains Buy on AGCO, Lowers Price Target to $150

By Benzinga Newsdesk
July 15, 8:43 AM
Jefferies analyst Stephen Volkmann maintains AGCO (NYSE:AGCO) with a Buy and lowers the price target from $170 to $150.

AGCO

Posts pagination

Previous 1 … 2,066 2,067 2,068 … 2,160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service